Inhibitors of the DUB proteins USP1, USP4, USP7, USP14, and USP33 have shown therapeutic effects in prostate cancer, lung cancer, breast cancer, and blood malignancies 24-28. This evidence concerns the gene USP7 and lung carcinoma.